Health economics of exome sequencing for rare disorders.

Deborah Schofield

doi:10.1016/j.pathol.2015.12.081

Abstract

Rare genetic disorders can have devastating health impacts on patients. A sometimes overlooked area of significant impact is the cost of the disorders. The results of a study of the relative cost of exome sequencing compared to usual care are presented, along with a review of the breadth of the costs of monogenic childhood disorders both within and beyond the health system.

Original language	English
Pages (from-to)	S32
Number of pages	1
Journal	Pathology
Volume	48
Issue number	S1
DOIs	https://doi.org/10.1016/j.pathol.2015.12.081
Publication status	Published - Feb 2016
Externally published	Yes
Event	Pathology Update (2016) - Victoria, Australia Duration: 26 Feb 2016 → 28 Feb 2016

Access to Document

10.1016/j.pathol.2015.12.081

Cite this

@article{f0d8d21835164ee0a4a827a5e013bd9a,

title = "Health economics of exome sequencing for rare disorders.",

abstract = "Rare genetic disorders can have devastating health impacts on patients. A sometimes overlooked area of significant impact is the cost of the disorders. The results of a study of the relative cost of exome sequencing compared to usual care are presented, along with a review of the breadth of the costs of monogenic childhood disorders both within and beyond the health system.",

author = "Deborah Schofield",

year = "2016",

month = feb,

doi = "10.1016/j.pathol.2015.12.081",

language = "English",

volume = "48",

pages = "S32",

journal = "Pathology",

issn = "0031-3025",

publisher = "Elsevier",

number = "S1",

note = "Pathology Update (2016) ; Conference date: 26-02-2016 Through 28-02-2016",

}

TY - JOUR

T1 - Health economics of exome sequencing for rare disorders.

AU - Schofield, Deborah

PY - 2016/2

Y1 - 2016/2

N2 - Rare genetic disorders can have devastating health impacts on patients. A sometimes overlooked area of significant impact is the cost of the disorders. The results of a study of the relative cost of exome sequencing compared to usual care are presented, along with a review of the breadth of the costs of monogenic childhood disorders both within and beyond the health system.

AB - Rare genetic disorders can have devastating health impacts on patients. A sometimes overlooked area of significant impact is the cost of the disorders. The results of a study of the relative cost of exome sequencing compared to usual care are presented, along with a review of the breadth of the costs of monogenic childhood disorders both within and beyond the health system.

U2 - 10.1016/j.pathol.2015.12.081

DO - 10.1016/j.pathol.2015.12.081

M3 - Meeting abstract

C2 - 27773014

SN - 0031-3025

VL - 48

SP - S32

JO - Pathology

JF - Pathology

IS - S1

T2 - Pathology Update (2016)

Y2 - 26 February 2016 through 28 February 2016

ER -

Health economics of exome sequencing for rare disorders.

Abstract

Access to Document

Fingerprint

Cite this